U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 215974

SUNLENCA (LENACAPAVIR SODIUM)
EQ 300MG BASE
Marketing Status: Prescription
Active Ingredient: LENACAPAVIR SODIUM
Proprietary Name: SUNLENCA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 300MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N215974
Product Number: 001
Approval Date: Dec 22, 2022
Applicant Holder Full Name: GILEAD SCIENCES INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top